Cargando…

Comparison of Treatment Adherence between Selective Serotonin Reuptake Inhibitors and Moclobemide in Patients with Social Anxiety Disorder

OBJECTIVE: With respect to the pharmacotherapy of social anxiety disorder (SAD), it has been suggested that treatment duration is an important factor that can significantly predict responses. The present study aimed to compare the treatment adherence of SAD patients who were taking either SSRIs or r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Se-Won, Kwon, Yong-Seok, Ha, Juwon, Yoon, Hyeng-Geun, Bae, Seung-Min, Shin, Dong-Won, Shin, Young-Chul, Oh, Kang-Seob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285744/ https://www.ncbi.nlm.nih.gov/pubmed/22396688 http://dx.doi.org/10.4306/pi.2012.9.1.73

Ejemplares similares

Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study
por: Oh, Kang-Seob, et al.
Publicado: (2016)

The Relationship between Plasma Oxytocin Levels and Social Anxiety Symptoms
por: Oh, Kang-Seob, et al.
Publicado: (2018)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K(+) channels in coronary arterial smooth muscle cells
por: Kim, Han Sol, et al.
Publicado: (2017)

Effect of selective serotonin reuptake inhibitor discontinuation on anxiety-like behaviours in mice
por: Collins, Helen M, et al.
Publicado: (2022)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

The Necessity of Bone Densitometry for Patients Taking Selective Serotonin Reuptake Inhibitors
por: An, Ki-Yong, et al.
Publicado: (2013)

Comparison of the efficacy and safety of moclobemide and imipramine in the treatment of depression in Indian patients
por: Avasthi, Ajit, et al.
Publicado: (2005)

Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies
por: Yoon, Hyungkun, et al.
Publicado: (2018)

Influence of the endocannabinoid system on the antidepressant activity of bupropion and moclobemide in the behavioural tests in mice
por: Poleszak, Ewa, et al.
Publicado: (2020)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Structural Requirements for Modulating 4-Benzylpiperidine Carboxamides from Serotonin/Norepinephrine Reuptake Inhibitors to Triple Reuptake Inhibitors
por: Paudel, Suresh, et al.
Publicado: (2021)

It is never too late to treat anxiety neurosis or panic disorder with a serotonin-reuptake inhibitor
por: Bech, Per, et al.
Publicado: (2014)

Measures of Connectivity and Dorsolateral Prefrontal Cortex Volumes and Depressive Symptoms Following Treatment With Selective Serotonin Reuptake Inhibitors in Adolescents
por: Lee, Kyung Hwa, et al.
Publicado: (2023)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Improvement of Post Stroke Echolalia after Using Selective Serotonin Reuptake Inhibitors
por: Bae, Heewon, et al.
Publicado: (2019)

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)

Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects
por: Shin, Dongseong, et al.
Publicado: (2017)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Cellular Correlates of Enhanced Anxiety Caused by Acute Treatment with the Selective Serotonin Reuptake Inhibitor Fluoxetine in Rats
por: Ravinder, Shilpa, et al.
Publicado: (2011)

Trajectories of Depressive and Anxiety Symptoms Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor‐Treated Women
por: Mesches, Gabrielle A., et al.
Publicado: (2022)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Biological and Histopathological Investigations of Moclobemide on Injured Ovarian Tissue Following Induction of Ischemia-Reperfusion in Rats
por: Ingec, Metin, et al.
Publicado: (2012)

Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
por: Vahid-Ansari, Faranak, et al.
Publicado: (2019)

Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity
por: Tiradentes, R.V., et al.
Publicado: (2014)

Binge eating is associated with trait anxiety in Korean adolescent girls: a cross sectional study
por: Jung, Jin-Yi, et al.
Publicado: (2017)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Briley, Mike, et al.
Publicado: (2010)

Prenatal exposure to serotonin reuptake inhibitors: a case report
por: Marsella, Maria, et al.
Publicado: (2010)

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment
por: Alexeev, Vasiliy Grigorievich, et al.
Publicado: (2011)

Hyperprolactinemia and breast enlargement with serotonin reuptake inhibitor and olanzapine combination
por: Praharaj, Samir Kumar
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2ijj0lbbnei3hu9tknpgjmtnrv